Obesity, an added misery in patients with PsA

Key clinical point: Obesity was associated with a higher disease activity and poorer quality of life (QoL) in patients with psoriatic arthritis (PsA), thus emphasizing the need to consider obesity during the management of patients with PsA.

Major finding: Patients with obesity had a significantly higher PsA QoL questionnaire and psychological status measured by the Hospital Anxiety and Depression Scale compared with nonobese patients (P < .001). Even the disease activity index for PsA score was higher in patients with obesity (P < .05), whereas Psoriasis Area and Severity Index was similar between both groups (P = .154).

Study details: Findings are from a cross-sectional study including 1,033 patients with PsA, of which 62.9% of patients were nonobese and 37.1% were obese.

Disclosures: This study did not report any source of funding. The authors declared no conflicts of interest.

Source: Gok K et al. Rheumatol Int. 2021 Aug 28. doi: 10.1007/s00296-021-04971-8.

Key clinical point: Obesity was associated with a higher disease activity and poorer quality of life (QoL) in patients with psoriatic arthritis (PsA), thus emphasizing the need to consider obesity during the management of patients with PsA.

Major finding: Patients with obesity had a significantly higher PsA QoL questionnaire and psychological status measured by the Hospital Anxiety and Depression Scale compared with nonobese patients (P < .001). Even the disease activity index for PsA score was higher in patients with obesity (P < .05), whereas Psoriasis Area and Severity Index was similar between both groups (P = .154).

Study details: Findings are from a cross-sectional study including 1,033 patients with PsA, of which 62.9% of patients were nonobese and 37.1% were obese.

Disclosures: This study did not report any source of funding. The authors declared no conflicts of interest.

Source: Gok K et al. Rheumatol Int. 2021 Aug 28. doi: 10.1007/s00296-021-04971-8.

Key clinical point: Obesity was associated with a higher disease activity and poorer quality of life (QoL) in patients with psoriatic arthritis (PsA), thus emphasizing the need to consider obesity during the management of patients with PsA.

Major finding: Patients with obesity had a significantly higher PsA QoL questionnaire and psychological status measured by the Hospital Anxiety and Depression Scale compared with nonobese patients (P < .001). Even the disease activity index for PsA score was higher in patients with obesity (P < .05), whereas Psoriasis Area and Severity Index was similar between both groups (P = .154).

Study details: Findings are from a cross-sectional study including 1,033 patients with PsA, of which 62.9% of patients were nonobese and 37.1% were obese.

Disclosures: This study did not report any source of funding. The authors declared no conflicts of interest.

Source: Gok K et al. Rheumatol Int. 2021 Aug 28. doi: 10.1007/s00296-021-04971-8.